atovaquone has been researched along with Graft vs Host Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chaudhry, A; Dabas, R; Daly, A; Dharmani-Khan, P; Dowhan, M; Duggan, P; Evernden, C; Gregson, D; Jamani, K; Jimenez-Zepeda, V; Johnson, A; Jupp, J; Kalra, A; Khan, F; Storek, J; Tay, J | 1 |
1 other study(ies) available for atovaquone and Graft vs Host Disease
Article | Year |
---|---|
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antilymphocyte Serum; Atovaquone; CD4 Lymphocyte Count; Dapsone; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Lymphopenia; Male; Middle Aged; Pentamidine; Pneumocystis carinii; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2020 |